To validate the use of K-RasG12D mice as a model with which to study the effects of ROS1 targeting in NSCLC, we evaluated ROS1 expression in the lungs and extrathoracic lesions of these mice. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.